Rapid diagnostic imaging and targeted immunotoxin delivery in aggressive prostate cancer using CEACAM5-specific nanobodies
Abstract Aggressive variant prostate cancer (AVPC) originates from metastatic prostate cancer (mPCa) following androgen receptor-targeted therapies, leading to diverse pathological subtypes, notably castration-resistant prostate cancer (CRPC). Carcinoembryonic antigen-related cell adhesion molecule...
Saved in:
| Main Authors: | Zhaoming Xiao, Jingbo Ma, Jinpeng Cen, Tao Xie, Liuhai Zheng, Guangwei Shi, Zhifen Li, Yang Li, Chengming Qu, Yuanqiao He, Chong Wang, Jun Xiao, Haibo Jiang, Zhijie Li, Jigang Wang, Shan-Chao Zhao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-07-01
|
| Series: | Journal of Nanobiotechnology |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12951-025-03600-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
GRP78 Nanobody‐Directed Immunotoxin Activates Innate Immunity Through STING Pathway to Synergize Tumor Immunotherapy
by: Huifang Wang, et al.
Published: (2025-05-01) -
Safety of unconventional antibody-drug conjugate L-DOS47 in a phase I/II monotherapy study targeting advanced NSCLC
by: Rodryg Ramlau, et al.
Published: (2025-08-01) -
Development of a radiomic model to predict CEACAM1 expression and prognosis in ovarian cancer
by: Xiaoxue Zhang, et al.
Published: (2025-04-01) -
Unlocking the potential of engineered microbes in immunotoxin-based cancer therapy
by: Quan Wang, et al.
Published: (2025-06-01) -
Nanobodies: From Discovery to AI-Driven Design
by: Haoran Zhu, et al.
Published: (2025-05-01)